Details for Patent: 8,298,568

Which drugs does patent 8,298,568 protect, and when does it expire?

Patent 8,298,568 protects VERKAZIA and is included in one NDA.

This patent has seventy-one patent family members in eighteen countries.

Summary for Patent: 8,298,568

Title:	Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential
Abstract:	A well tolerated oil-in-water emulsion useful as a delivery vehicle of hydrophobic ingredients such as pharmaceutical drugs, wherein the emulsion particles have a net positive charge and comprises 0.001 to 0.1% of a cationic agent, 0 to 1% of a non ionic surfactant and 0 to 0.5% of an anionic surfactant.
Inventor(s):	Bague; Severine (Marcoussis, FR), Philips; Betty (Antony, FR), Garrigue; Jean-Sebastien (Verrieres le Buisson, FR), Rabinovich-Guilatt; Laura (Paris, FR), Lambert; Gregory (Malabry, FR)
Assignee:	Novagali Pharma SA (Evry, FR)
Application Number:	10/991,346
Patent Claim Types: see list of patent claims	Composition;

Drugs Protected by US Patent 8,298,568

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Harrow Eye	VERKAZIA	cyclosporine	EMULSION;OPHTHALMIC	214965-001	Jun 23, 2021		RX	Yes	Yes			Y

Foreign Priority and PCT Information for Patent: 8,298,568

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	04292645	Nov 9, 2004

International Family Members for US Patent 8,298,568

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	E412400
Austria	E412401
Austria	E415942
Austria	E418964
Austria	E479424